Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK

Research output: Contribution to journalArticlepeer-review


  • H M Earl
  • L Hiller
  • J Dunn
  • I Macpherson
  • L Hughes-Davies
  • K McAdam
  • P Hall
  • J Mansi
  • D Wheatley
  • J E Abraham
  • C Caldas
  • S Gasson
  • E O'Riordan
  • M Wilcox
  • D Miles
  • D A Cameron
  • A Wardley

Colleges, School and Institutes

External organisations

  • Cancer Research UK Cambridge Institute
  • The University of Warwick
  • University of Glasgow
  • Cancer Research UK Clinical Trials Unit (CRCTU), School of Cancer Sciences, University of Birmingham, Birmingham, UK.
  • Institute of Cancer and Genomic Sciences
  • Cambridge University Hospitals NHS Foundation Trust
  • University of Edinburgh, The
  • Guy's and St Thomas' NHS Foundation Trust and King's College Medical School
  • Royal Cornwall Hospitals NHS Trust
  • Independent Cancer Patients Voice
  • Mount Vernon Cancer Centre, Mount Vernon Hospital, Northwood, UK.
  • Manchester University Hospitals NHS Foundation Trust


Original languageEnglish
JournalClinical Oncology
Publication statusE-pub ahead of print - 25 Jul 2020